SUVICA

suvica-logo

Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Currently, they have a small molecule protein synthesis inhibitor in pre-clinical development. SVC112 – With a patent filed for Composition of Matter protection, SVC112 has shown pre-clinical efficacy as monotherapy and in combination with standard therapies such as radiation and newly approved targeted agents. SVC112 is in pre-clinical development for a variety of cancer indications, including head & neck cancer, melanoma, colorectal cancer, and non-small cell lung cancer. It was founded in 2010 and is headquartered in Boulder, Colorado.

#SimilarOrganizations #People #Website #More

SUVICA

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2010-01-01

Address:
Boulder, Colorado, United States

Country:
United States

Website Url:
http://www.suvica.com

Total Employee:
1+

Status:
Active

Contact:
303-921-6680

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Organization Schema Apache Google Apps For Business Unified Layer ContactPoint Schema


Similar Organizations

alef-biotechnology-logo

Alef Biotechnology

Alef Biotechnology focused on the development of Medical Grade Cannabis products for the treatment of various medical conditions.

asc-therapeutics-logo

ASC Therapeutics

ASC Therapeutics is a biotechnology company that focuses on discovering and developing cures for intractable diseases.

bw-therapeutics-logo

BW Therapeutics

Founded in 2019 as a biotechnology company focused on the development of TYN-21, a 505(b)(2) formulation of Abraxane.

not_available_image

GliaMed

GliaMed is a development-stage biopharmaceutical company dedicated to the discovery and development of small molecule drugs which enhance

mangogen-pharma-logo

MangoGen Pharma

MangoGen is a biotechnology company that engages in the research and development of gene delivering cardiac stents and wound healing creams.

nodthera-logo

NodThera

NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.

not_available_image

Pennsylvania Biotechnology Association

Pennsylvania Biotechnology Association attests to the tensile strength of this region as a world-class biopharmaceutical center.

via-pharmaceuticals-logo

VIA Pharmaceuticals

VIA Pharmaceuticals is a biotechnology company focused on the development of small-molecule drugs to treat cardiovascular diseases.

virginia-catalyst-logo

Virginia Catalyst

Virginia Catalyst is a nonprofit corporation focusing on economic development through life sciences discoveries.

Current Employees Featured

not_available_image

Wendi Pevler
Wendi Pevler CFO @ Suvica
CFO

tin-tin-su_image

Tin Tin Su
Tin Tin Su CSO and Co-Founder @ Suvica
CSO and Co-Founder
2010-07-01

not_available_image

Gijsbertus Pronk
Gijsbertus Pronk VP Preclinical Development @ Suvica
VP Preclinical Development
2012-10-01

judy-hemberger_image

Judy Hemberger
Judy Hemberger CEO @ Suvica
CEO
2011-06-01

Founder


tin-tin-su_image

Tin Tin Su

Official Site Inspections

http://www.suvica.com Semrush global rank: 15.76 M Semrush visits lastest month: 46

  • Host name: 192-254-236-52.unifiedlayer.com
  • IP address: 192.254.236.52
  • Location: Houston United States
  • Latitude: 29.8284
  • Longitude: -95.4696
  • Metro Code: 618
  • Timezone: America/Chicago
  • Postal: 77092

Loading ...

More informations about "Suvica"

Suvica - Crunchbase Company Profile & Funding

Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Currently, they …See details»

SuviCa

SuviCa’s compounds target an under-exploited cellular mechanism that is critical for cancer re-growth after treatment with these standard cancer therapies, providing opportunities for new treatment combinations. Read more. News & …See details»

SuviCa’s Management Team

Mrs. Petro is a graduate of CU Denver, MBA (Finance), MS (Management & Organization). ... SuviCa Scientists Co-author a Paper on SuviCa’s lead compound; SuviCa Awarded a Phase II …See details»

SuviCa 2025 Company Profile: Valuation, Funding & Investors

SuviCa General Information Description. Developer of small molecules discovery platform designed for cancer treatment. The company's platform develops a compound that targets an …See details»

SUVICA, INC. - VentureRadar

Suvica is focused on the discovery and development of small molecule cancer therapeutics targeting a unique mechanism of action. SuviCa identifies potential candidates through …See details»

SuviCa, Inc. Company Profile | Estes Park, CO - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for SuviCa, Inc. of Estes Park, CO. Get the latest business insights from Dun & Bradstreet.See details»

Suvica - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Suvica . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Contacts 2. ... Suvica has 4 current …See details»

Suvica - Crunchbase

Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Search Crunchbase. Start Free Trial . Chrome …See details»

SuviCa, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore SuviCa, Inc. with its drug pipeline, therapeutic area, technology platform, 5 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule drug ...See details»

SuviCA - Products, Competitors, Financials, Employees, …

SuviCa, Inc. is focused on the discovery and development of small molecules for the treatment of cancer. The company's main offerings include pre-clinical development of a small molecule …See details»

SuviCa - Overview, News & Similar companies | ZoomInfo.com

SuviCa contact info: Phone number: (303) 921-6680 Website: www.suvica.com What does SuviCa do? SuviCa, Inc. is focused on the discovery and development of small molecules for …See details»

Scientific Advisory Board - SuviCa

David Raben | MD FASTRO VP, Product Development Oncology, Global Head LASR Franchise at Genentech, Professor of Radiation Oncology. Dr. Raben is nationally recognized for his …See details»

Start-up gets $1.5 million to develop cancer drug | Colorado Arts ...

Oct 15, 2015 SuviCa Inc. of Boulder, a University of Colorado Boulder biotech start-up company, has been awarded roughly $1.5 million in federal funding to develop novel treatments for head …See details»

Nextsource | Company Profile | Suvica

Uncover shifts in customer sentiment around Suvica through recent reviews or social media mentions. Find out if Suvica is undergoing leadership changes or executive team restructuring. …See details»

Partnering & Business Opportunities | SuviCa

SuviCa’s technology has been recognized as important by scientific and business reviewers at state and federal bodies who have provided financial support. The ideal partner(s) would be an …See details»

Suvica - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Search Crunchbase. Start Free Trial . Chrome …See details»

Boulder company taking CU-Boulder cancer-screening ... - CU …

Sep 21, 2011 SuviCa Inc. is an early-stage cancer drug discovery and development company co-founded by Su, who now serves as its chief science officer. Judith Hemberger, a former co …See details»

Our Technology - SuviCa

SuviCa is taking advantage of this under-utilized area to develop drugs to target hematological and solid tumors. For a recent publication, please visit …See details»

Product Pipeline - SuviCa

SuviCa’s Pipeline. Currently, SuviCa has a small molecule protein synthesis inhibitor in pre-clinical development. SVC112 – With a patent filed for Composition of Matter protection, …See details»

News & Releases - SuviCa

A manuscript entitled ‘Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma’ and co-authored by …See details»

linkstock.net © 2022. All rights reserved